Aurel Prosz
Aurel Prosz
1Danish Cancer Institute, Copenhagen, Denmark
1,#,
Pranshu Sahgal
Pranshu Sahgal
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA USA
4Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA USA
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA USA
2,3,4,5,#,
Brandon M Huffman
Brandon M Huffman
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
6Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2,6,
Zsofia Sztupinszki
Zsofia Sztupinszki
1Danish Cancer Institute, Copenhagen, Denmark
4Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA USA
1,4,
Clare X Morris
Clare X Morris
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2,
David Chen
David Chen
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
7Temerty Faculty of Medicine, University of Toronto, Toronto, ON Canada
2,7,
Judit Börcsök
Judit Börcsök
1Danish Cancer Institute, Copenhagen, Denmark
1,
Miklos Diossy
Miklos Diossy
1Danish Cancer Institute, Copenhagen, Denmark
4Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA USA
1,4,
Viktoria Tisza
Viktoria Tisza
8Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary
8,
Sandor Spisak
Sandor Spisak
8Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary
8,
Pornlada Likasitwatanakul
Pornlada Likasitwatanakul
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA USA
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA USA
2,3,5,
Orsolya Rusz
Orsolya Rusz
92nd Department of Pathology, SE NAP, Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary
9,
Istvan Csabai
Istvan Csabai
10Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary
10,
Michael Cecchini
Michael Cecchini
11Department of Medical Oncology, Center for Gastrointestinal Cancers, Yale Medical Center, New Haven, CT USA
11,
Yasmine Baca
Yasmine Baca
12Caris Life Sciences, Phoenix, AZ USA
12,
Andrew Elliott
Andrew Elliott
12Caris Life Sciences, Phoenix, AZ USA
12,
Peter Enzinger
Peter Enzinger
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA USA
6Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2,3,6,
Harshabad Singh
Harshabad Singh
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA USA
6Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2,3,6,
Jessalyn Ubellaker
Jessalyn Ubellaker
13Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA USA
13,
Jean-Bernard Lazaro
Jean-Bernard Lazaro
14Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA USA
15Center for DNA Damage and Repair (CDDR), Dana-Farber Cancer Institute, Boston, MA USA
14,15,
James M Cleary
James M Cleary
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA USA
6Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2,3,6,
Zoltan Szallasi
Zoltan Szallasi
1Danish Cancer Institute, Copenhagen, Denmark
4Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA USA
16Department of Bioinformatics and Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary
1,4,16,✉,
Nilay S Sethi
Nilay S Sethi
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA USA
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA USA
6Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
2,3,5,6,✉
1Danish Cancer Institute, Copenhagen, Denmark
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
3Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA USA
4Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA USA
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, MA USA
6Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA USA
7Temerty Faculty of Medicine, University of Toronto, Toronto, ON Canada
8Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary
92nd Department of Pathology, SE NAP, Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary
10Department of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary
11Department of Medical Oncology, Center for Gastrointestinal Cancers, Yale Medical Center, New Haven, CT USA
12Caris Life Sciences, Phoenix, AZ USA
13Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA USA
14Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA USA
15Center for DNA Damage and Repair (CDDR), Dana-Farber Cancer Institute, Boston, MA USA
16Department of Bioinformatics and Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary
Subject terms: Cancer genomics, High-throughput screening
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
